Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma.

Administration of glucocorticoids induces ocular hypertension in some patients. If untreated, these patients can develop a secondary glaucoma that resembles primary open-angle glaucoma (POAG). The underlying pathology of glucocorticoid-induced glaucoma is not fully understood, due in part to lack of an appropriate animal model. Here, we developed a murine model of glucocorticoid-induced glaucoma that exhibits glaucoma features that are observed in patients. Treatment of WT mice with topical ocular 0.1% dexamethasone led to elevation of intraocular pressure (IOP), functional and structural loss of retinal ganglion cells, and axonal degeneration, resembling glucocorticoid-induced glaucoma in human patients. Furthermore, dexamethasone-induced ocular hypertension was associated with chronic ER stress of the trabecular meshwork (TM). Similar to patients, withdrawal of dexamethasone treatment reduced elevated IOP and ER stress in this animal model. Dexamethasone induced the transcriptional factor CHOP, a marker for chronic ER stress, in the anterior segment tissues, and Chop deletion reduced ER stress in these tissues and prevented dexamethasone-induced ocular hypertension. Furthermore, reduction of ER stress in the TM with sodium 4-phenylbutyrate prevented dexamethasone-induced ocular hypertension in WT mice. Our data indicate that ER stress contributes to glucocorticoid-induced ocular hypertension and suggest that reducing ER stress has potential as a therapeutic strategy for treating glucocorticoid-induced glaucoma.

[1]  J. Danias,et al.  Steroid-induced ocular hypertension in normal cattle. , 2004, Archives of ophthalmology.

[2]  H. Yoshida.  [Molecular biology of the ER stress response]. , 2004, Seikagaku. The Journal of Japanese Biochemical Society.

[3]  Young H. Kwon,et al.  Primary open-angle glaucoma. , 2009, The New England journal of medicine.

[4]  R. Kaufman,et al.  The mammalian unfolded protein response. , 2003, Annual review of biochemistry.

[5]  J. Roth,et al.  Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis. , 2007, Investigative Ophthalmology and Visual Science.

[6]  M. F. Armaly.  EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. I. THE EFFECT OF DEXAMETHASONE IN THE NORMAL EYE. , 1963, Archives of ophthalmology.

[7]  Subramaniam Pennathur,et al.  Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. , 2008, The Journal of clinical investigation.

[8]  D. Ron,et al.  Endoplasmic reticulum stress signaling in disease. , 2006, Physiological reviews.

[9]  Michael G Anderson,et al.  Complex genetics of glaucoma susceptibility. , 2005, Annual review of genomics and human genetics.

[10]  T. Yorio,et al.  Regulation of glucocorticoid responsiveness in glaucomatous trabecular meshwork cells by glucocorticoid receptor-beta. , 2005, Investigative ophthalmology & visual science.

[11]  A. Clark,et al.  The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. , 1992, Investigative ophthalmology & visual science.

[12]  B. Becker,et al.  INTRAOCULAR PRESSURE RESPONSE TO TOPICAL CORTICOSTEROIDS. , 1965, Investigative ophthalmology.

[13]  E. Lütjen-Drecoll,et al.  Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. , 1997, Archives of ophthalmology.

[14]  D. Rice,et al.  Increased intraocular pressure in mice treated with dexamethasone. , 2010, Investigative ophthalmology & visual science.

[15]  Anders Heijl,et al.  Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. , 2003, Archives of ophthalmology.

[16]  J. Danias,et al.  Steroid-induced ocular hypertension in normal sheep. , 2009, Investigative ophthalmology & visual science.

[17]  O. Lorenzetti.  Effects of corticosteroids on ocular dynamics in rabbits. , 1970, The Journal of pharmacology and experimental therapeutics.

[18]  M. Jung,et al.  ATM blocks tunicamycin‐induced endoplasmic reticulum stress , 2009, FEBS letters.

[19]  Michael G. Anderson,et al.  High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Ron,et al.  CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. , 2004, Genes & development.

[21]  B. Becker,et al.  Steroid-induced elevation of intraocular pressure. , 1963, Archives of ophthalmology.

[22]  Michael G. Anderson,et al.  Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. , 2011, The Journal of clinical investigation.

[23]  J. Rohen,et al.  Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid-glaucoma. , 1973, Experimental eye research.

[24]  M. F. Armaly.  EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. II. THE EFFECT OF DEXAMETHASONE IN THE GLAUCOMATOUS EYE. , 1963, Archives of ophthalmology.

[25]  V. Sheffield,et al.  Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. , 2001, Investigative ophthalmology & visual science.

[26]  R. Wordinger,et al.  Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma , 1999, Progress in Retinal and Eye Research.

[27]  S. Sawaguchi,et al.  Myocilin Gene Expression in the Trabecular Meshwork of Rats in a Steroid-Induced Ocular Hypertension Model , 2005, Ophthalmic Research.

[28]  L. Bito,et al.  Steroid glaucoma: corticosteroid-induced ocular hypertension in cats. , 1992, Experimental eye research.

[29]  W. Alkema,et al.  Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells. , 2011, Cellular signalling.

[30]  H. Quigley,et al.  Neuronal death in glaucoma , 1999, Progress in Retinal and Eye Research.

[31]  V. Sheffield,et al.  Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. , 2001, Investigative ophthalmology & visual science.

[32]  S. Oyadomari,et al.  Roles of CHOP/GADD153 in endoplasmic reticulum stress , 2004, Cell Death and Differentiation.

[33]  C. R. Ethier,et al.  Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. , 2005, Cell motility and the cytoskeleton.

[34]  Xiaozhong Wang,et al.  CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. , 1998, Genes & development.

[35]  D. Rhee,et al.  Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. , 2006, Current opinion in ophthalmology.

[36]  H. Quigley.  Number of people with glaucoma worldwide. , 1996, The British journal of ophthalmology.

[37]  T. Yorio,et al.  Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells. , 2012, Investigative ophthalmology & visual science.

[38]  H. Yamaguchi,et al.  CHOP Is Involved in Endoplasmic Reticulum Stress-induced Apoptosis by Enhancing DR5 Expression in Human Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[39]  J. Rohen,et al.  Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). , 1993, Experimental eye research.

[40]  T. Yorio,et al.  Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma. , 2011, Investigative ophthalmology & visual science.

[41]  J. Danias,et al.  Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes. , 2013, Investigative ophthalmology & visual science.

[42]  B. Becker,et al.  CORTICOSTEROIDS AND INTRAOCULAR PRESSURE. , 1963, Archives of ophthalmology.

[43]  Chris A. Johnson,et al.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. , 2002, Archives of ophthalmology.

[44]  V. Sheffield,et al.  Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. , 2001, Investigative ophthalmology & visual science.

[45]  H. Quigley,et al.  The number of people with glaucoma worldwide in 2010 and 2020 , 2006, British Journal of Ophthalmology.

[46]  R. Sihota,et al.  Prospective, long-term evaluation of steroid-induced glaucoma , 2008, Eye.

[47]  D. Broadway,et al.  Corticosteroid-induced glaucoma: a review of the literature , 2006, Eye.

[48]  Michael G. Anderson,et al.  Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma. , 2012, Investigative ophthalmology & visual science.

[49]  V. Sheffield,et al.  Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. , 2007, Human molecular genetics.

[50]  W. Stamer,et al.  Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X. , 2013, Investigative ophthalmology & visual science.

[51]  Richard S. Smith,et al.  Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma , 2004, Molecular and Cellular Biology.

[52]  A. Clark,et al.  The role of steroids in outflow resistance. , 2009, Experimental eye research.

[53]  A. Bill.  Editorial: The drainage of aqueous humor. , 1975, Investigative ophthalmology.

[54]  J. Rohen,et al.  Electron microscopic studies on the trabecular meshwork in two cases of corticosteriod-glaucoma , 1973 .

[55]  Hiderou Yoshida,et al.  ER stress and diseases , 2007, The FEBS journal.